The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Open accessAbstract
Since the first description of their opioid properties three decades ago, dynorphins have increasingly been thought to play a regulatory role in numerous functional pathways of the brain. Dynorphins are members of the opioid peptide family and preferentially bind to kappa opioid receptors. In line with their localization in the hippocampus, amygdala, hypothalamus, striatum and spinal cord, their functions are related to learning and memory, emotional control, stress response and pain. Pathophysiological mechanisms that may involve dynorphins/kappa opioid receptors include epilepsy, addiction, depression and schizophrenia. Most of these functions were proposed in the 1980s and 1990s following histochemical, pharmacological and electrophysiological experiments using kappa receptor-specific or general opioid receptor agonists and antagonists in animal models. However, at that time, we had little information on the functional relevance of endogenous dynorphins. This was mainly due to the complexity of the opioid system. Besides actions of peptides from all three classical opioid precursors (proenkephalin, prodynorphin, proopiomelanocortin) on the three classical opioid receptors (delta, mu and kappa), dynorphins were also shown to exert non-opioid effects mainly through direct effects on NMDA receptors. Moreover, discrepancies between the distribution of opioid receptor binding sites and dynorphin immunoreactivity contributed to the difficulties in interpretation. In recent years, the generation of prodynorphin- and opioid receptor-deficient mice has provided the tools to investigate open questions on network effects of endogenous dynorphins. This article examines the physiological, pathophysiological and pharmacological implications of dynorphins in the light of new insights in part obtained from genetically modified animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485 · cited 1×
“One year later, a third receptor termed δ (delta for deferens) was described from mouse vas deferens and guinea pig ileum (Lord et al., 1977).”
BackgroundThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Cox, B. M., Opheim, K. E., Teschemacher, H., & Goldstein, A. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90272-6 · Cited by 1,708
Efferent connections of the substantia nigra and ventral tegmental area in the rat
Beckstead, R. M., Domesick, V. B., & Nauta, W. J. H. (1979) · Brain Research · doi:10.1016/0006-8993(79)91001-1 · Cited by 1,293
Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801
Trujillo, K. A., & Akil, H. (1991) · Science · doi:10.1126/science.1824728 · Cited by 1,210
Amygdala–frontal connectivity during emotion regulation
Banks, S. J., Eddy, K. T., Angstadt, M., Nathan, P. J., & Phan, K. L. (2007) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsm029 · Cited by 1,187 · cited 1×
“In addition, the importance of the amygdala-frontal connectivity during emotional regulation was shown by fMRI (Banks et al., 2007).”
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
Fear and anxiety: Animal models and human cognitive psychophysiology
Lang, P. J., Davis, M., & Öhman, A. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00343-8 · Cited by 1,162
Neuregulins: functions, forms, and signaling strategies
Falls, D. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00102-7 · Cited by 1,071
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 1×
“E urope PM C Funders A uthor M anuscripts E urope PM C Funders A uthor M anuscripts Dyn/KOP on stress-induced reinstatement of cocaine and amphetamine seeking behaviour was proposed by several studies (for review see Koob, 2008).”
MethodLong story short: the serotonin transporter in emotion regulation and social cognition
Canli, T., & Lesch, K.-P. (2007) · Nature Neuroscience · doi:10.1038/nn1964 · Cited by 1,034 · cited 1×
“…source of antidepressant drugs and alterations in serotonin transporter expression were shown to be associated with emotional regulation and social cognition, but also anxietyrelated traits and susceptibility to depression (for reviews see Canli and Lesch, 2007; Lesch, 2007; Lowry et al., 2008).”
BackgroundOpposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
Activity-dependent neuronal plasticity following tissue injury and inflammation
Dubner, R., & Ruda, M. A. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90019-5 · Cited by 926
Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919 · cited 2×
“, 1996) and inactivation of CRH receptor 1 reduces anxiety (Smith et al., 1998; Timpl et al., 1998) whereas deletion of CRH receptor 2 is anxiogenic (Bale et al.”
BackgroundThe GTP-binding protein, Go9 regulates neuronal calcium channels
Hescheler, J., Rosenthal, W., Trautwein, W., & Schultz, G. (1987) · Nature · doi:10.1038/325445a0 · Cited by 904
Smith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80491-2 · Cited by 892
Dynorphin-(1-13), an extraordinarily potent opioid peptide.
Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., & Hood, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6666 · Cited by 882
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Bale, T. L., Contarino, A., Smith, G. W., Chan, R., Gold, L. H., Sawchenko, P. E., Koob, G. F., Vale, W. W., & Lee, K.-F. (2000) · Nature Genetics · doi:10.1038/74263 · Cited by 849
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
Vonvoigtlander, P. F., Lahti, R. A., & Ludens, J. H. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33422-1 · Cited by 805
Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor
Kakidani, H., Furutani, Y., Takahashi, H., Noda, M., Morimoto, Y., Hirose, T., Asai, M., Inayama, S., Nakanishi, S., & Numa, S. (1982) · Nature · doi:10.1038/298245a0 · Cited by 783
International Union of Pharmacology. XII. Classification of opioid receptors
Dhawan, B., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P., Portoghese, P., & Hamon, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06958-3 · Cited by 732
Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I., & Reisine, T. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09932-8 · Cited by 665
The basal ganglia: learning new tricks and loving it
Graybiel, A. M. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.10.006 · Cited by 649
Houser, C., Miyashiro, J., Swartz, B., Walsh, G., Rich, Jr., & Delgado-Escueta, A. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-01-00267.1990 · Cited by 619
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T., & Bell, G. I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6736 · Cited by 618
Mu and delta receptors belong to a family of receptors that are coupled to potassium channels.
North, R. A., Williams, J. T., Surprenant, A., & Christie, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5487 · Cited by 618
The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
Coste, S. C., Kesterson, R. A., Heldwein, K. A., Stevens, S. L., Heard, A. D., Hollis, J. H., Murray, S. E., Hill, J. K., Pantely, G. A., Hohimer, A. R., et al. (2000) · Nature Genetics · doi:10.1038/74255 · Cited by 590
DREAM is a Ca2+-regulated transcriptional repressor
Carrión, A. M., Link, W. A., Ledo, F., Mellström, B., & Naranjo, J. R. (1999) · Nature · doi:10.1038/18044 · Cited by 573
Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides
Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., & Heilig, M. (1993) · Science · doi:10.1126/science.8380941 · Cited by 527
Wilson, C. J., & Groves, P. M. (1980) · Journal of Comparative Neurology · doi:10.1002/cne.901940308 · Cited by 526
Distribution of dynorphin and enkephalin peptides in the rat brain
Fallon, J. H., & Leslie, F. M. (1986) · Journal of Comparative Neurology · doi:10.1002/cne.902490302 · Cited by 526
Bals-Kubik, R., Ableitner, A., Herz, A., & Shippenberg, T. S. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10296-6 · Cited by 524
The locus coeruleus: A cytoarchitectonic, golgi and immunohistochemical study in the albino rat
Swanson, L. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90207-9 · Cited by 518
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
Kishimoto, T., Radulovic, J., Radulovic, M., Lin, C. R., Schrick, C., Hooshmand, F., Hermanson, O., Rosenfeld, M. G., & Spiess, J. (2000) · Nature Genetics · doi:10.1038/74271 · Cited by 502
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jones, R. M., Portoghese, P. S., & Carlezon, W. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046433 · Cited by 485
Robertson, G. S., & Fibiger, H. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90054-6 · Cited by 474
Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology
Harrison, P. J., & Law, A. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.002 · Cited by 463
McLaughlin, J. P., Marton-Popovici, M., & Chavkin, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05674.2003 · Cited by 430
Cloning and pharmacological characterization of a rat kappa opioid receptor.
Meng, F., Xie, G. X., Thompson, R. C., Mansour, A., Goldstein, A., Watson, S. J., & Akil, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9954 · Cited by 426
Specific receptor for the opioid peptide dynorphin: structure--activity relationships.
Chavkin, C., & Goldstein, A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6543 · Cited by 423
CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN
KOSTERLITZ, H. W., PATERSON, S. J., & ROBSON, L. E. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb08749.x · Cited by 422
Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., & Kieffer, B. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.886 · Cited by 418
Simon, H., Le Moal, M., & Calas, A. (1979) · Brain Research · doi:10.1016/0006-8993(79)90085-4 · Cited by 401
Goldstein, A., Fischli, W., Lowney, L. I., Hunkapiller, M., & Hood, L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7219 · Cited by 399
Carlezon, W. A., Béguin, C., DiNieri, J. A., Baumann, M. H., Richards, M. R., Todtenkopf, M. S., Rothman, R. B., Ma, Z., Lee, D. Y.-W., & Cohen, B. M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092304 · Cited by 390
Dynorphin and the pathophysiology of drug addiction
Shippenberg, T. S., Zapata, A., & Chefer, V. I. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.011 · Cited by 387 · cited 3×
“…change at baseline (Marco et al., 2005) Alcohol consumption Reduction (Blednov et al., 2006) Reduction (Kovacs et al., 2005) Reduction (for review see Shippenberg et al., 2007) Acknowledgments I want to thank the Austrian and Tyrolean Science Funds and the Dr.Legerlotz Fund for continuous support.”
BackgroundMethodInfluentialTanaka, M., Yoshida, M., Emoto, H., & Ishii, H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00569-0 · Cited by 382
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358
Isolation and structural organization of the human preproenkephalin B gene
Horikawa, S., Takai, T., Toyosato, M., Takahashi, H., Noda, M., Kakidani, H., Kubo, T., Hirose, T., Inayama, S., Hayashida, H., et al. (1983) · Nature · doi:10.1038/306611a0 · Cited by 352
Weisskopf, M. G., Zalutsky, R. A., & Nicoll, R. A. (1993) · Nature · doi:10.1038/362423a0 · Cited by 336
Nguyen, T. V., Kosofsky, B. E., Birnbaum, R., Cohen, B. M., & Hyman, S. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4270 · Cited by 331
κ opioids selectively control dopaminergic neurons projecting to the prefrontal cortex
Margolis, E. B., Lock, H., Chefer, V. I., Shippenberg, T. S., Hjelmstad, G. O., & Fields, H. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511159103 · Cited by 325
Corticotropin-releasing factor and neuropeptide y: role in emotional integration
Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90079-5 · Cited by 324
Dynorphin immunocytochemistry in the rat central nervous system
Khachaturian, H., Watson, S. J., Lewis, M. E., Coy, D., Goldstein, A., & Akil, H. (1982) · Peptides · doi:10.1016/0196-9781(82)90063-8 · Cited by 320
Robertson, G. S., Matsumura, H., & Fibiger, H. C. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23800-9 · Cited by 309
Shirayama, Y., Ishida, H., Iwata, M., Hazama, G., Kawahara, R., & Duman, R. S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02589.x · Cited by 307
Pronociceptive actions of dynorphin maintain chronic neuropathic pain
Wang, Z., Gardell, L. R., Ossipov, M. H., Vanderah, T. W., Brennan, M. B., Hochgeschwender, U., Hruby, V. J., Malan, T. P., Lai, J., & Porreca, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01779.2001 · Cited by 301
McGinty, J. F., Henriksen, S. J., Goldstein, A., Terenius, L., & Bloom, F. E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.2.589 · Cited by 290
Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala
Narita, M., Kaneko, C., Miyoshi, K., Nagumo, Y., Kuzumaki, N., Nakajima, M., Nanjo, K., Matsuzawa, K., Yamazaki, M., & Suzuki, T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300858 · Cited by 289
Teschemacher, H., Opheim, K. E., Cox, B. M., & Goldstein, A. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90271-4 · Cited by 285
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria
Bruchas, M. R., Land, B. B., Aita, M., Xu, M., Barot, S. K., Li, S., & Chavkin, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3769-07.2007 · Cited by 281
Burke, M. C., Letts, P. A., Krajewski, S. J., & Rance, N. E. (2006) · Journal of Comparative Neurology · doi:10.1002/cne.21086 · Cited by 280 · cited 1×
“Neurons in the paraventricular and supraoptic nuclei, which represent two of the most important nuclei in the hypothalamic-pituitary unit, contain high amounts of pDyn (Burke et al., 2006).”
Backgroundκ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons
Margolis, E. B., Hjelmstad, G. O., Bonci, A., & Fields, H. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-31-09981.2003 · Cited by 275
DREAM Is a Critical Transcriptional Repressor for Pain Modulation
Cheng, H.-Y. M., Pitcher, G. M., Laviolette, S. R., Whishaw, I. Q., Tong, K. I., Kockeritz, L. K., Wada, T., Joza, N. A., Crackower, M., Goncalves, J., et al. (2002) · Cell · doi:10.1016/s0092-8674(01)00629-8 · Cited by 275
Naranjo, J., Mellström, B., Achaval, M., & Sassone-Corsit, P. (1991) · Neuron · doi:10.1016/0896-6273(91)90063-6 · Cited by 274
κ and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release
Mulder, A. H., Wardeh, G., Hogenboom, F., & Frankhuyzen, A. L. (1984) · Nature · doi:10.1038/308278a0 · Cited by 274
Wagner, J. J., Terman, G. W., & Chavkin, C. (1993) · Nature · doi:10.1038/363451a0 · Cited by 271
Opiate-dependent modulation of adenylate cyclase.
Sharma, S. K., Klee, W. A., & Nirenberg, M. W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.8.3365 · Cited by 269
Lowry, C. A., Hale, M. W., Evans, A. K., Heerkens, J., Staub, D. R., Gasser, P. J., & Shekhar, A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.004 · Cited by 268
Mansour, A., Hoversten, M. T., Taylor, L. P., Watson, S. J., & Akil, H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00928-j · Cited by 267
De Lanerolle, N. C., Kim, J. H., Williamson, A., Spencer, S. S., Zaveri, H. P., Eid, T., & Spencer, D. D. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.32701.x · Cited by 261
Bruchas, M. R., Macey, T. A., Lowe, J. D., & Chavkin, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513640200 · Cited by 258
Chen, Y., Mestek, A., Liu, J., & Yu, L. (1993) · Biochemical Journal · doi:10.1042/bj2950625 · Cited by 257
Simonin, F., Gavériaux-Ruff, C., Befort, K., Matthes, H., Lannes, B., Micheletti, G., Mattéi, M. G., Charron, G., Bloch, B., & Kieffer, B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7006 · Cited by 245
BindingDB (2012) · PubMed · doi:10.7270/q23j3bh2 · Cited by 242
Nonopiate Effects of Dynorphin and Des-Tyr-Dynorphin
Walker, J. M., Moises, H. C., Coy, D. H., Baldrighi, G., & Akil, H. (1982) · Science · doi:10.1126/science.6128791 · Cited by 237
Margolis, E. B., Mitchell, J. M., Ishikawa, J., Hjelmstad, G. O., & Fields, H. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1526-08.2008 · Cited by 234
Najavits, L. M., Gastfriend, D. R., Barber, J. P., Reif, S., Muenz, L. R., Blaine, J., Frank, A., Crits-Christoph, P., Thase, M., & Weiss, R. D. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.214 · Cited by 232
Dynorphin-immunoreactive neurons in the central nervous system of the rat
Vincent, S. R., Hökfelt, T., Christensson, I., & Terenius, L. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90249-x · Cited by 231
Kosten, T. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800080019003 · Cited by 229
Novel opiate binding sites selective for benzomorphan drugs.
Chang, K. J., Hazum, E., & Cuatrecasas, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4141 · Cited by 226
Knoll, A. T., Meloni, E. G., Thomas, J. B., Carroll, F. I., & Carlezon, W. A. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127415 · Cited by 225
Vandera, T. W., Laughlin, T., Lashbrook, J. M., Nichols, M. L., Wilcox, G. L., Ossipov, M. H., Malan, P. T., & Porreca, F. (1996) · Pain · doi:10.1016/s0304-3959(96)03225-3 · Cited by 224
Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway
Vincent, S., Hökfelt, T., Christensson, I., & Terenius, L. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90477-0 · Cited by 223
Valentino, R. J., Page, M., Van Bockstaele, E., & Aston-Jones, G. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90412-u · Cited by 222
On serotonin and experimental anxiety
Graeff, F. G. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1112-4 · Cited by 215
Laughlin, T. M., Vanderah, T. W., Lashbrook, J., Nichols, M. L., Ossipov, M., Porreca, F., & Wilcox, G. L. (1997) · Pain · doi:10.1016/s0304-3959(97)00046-8 · Cited by 200
Molecular cloning and expression of a rat κ opioid receptor
Li, S., Zhu, J., Chen, C., Chen, Y. W., Deriel, J. K., Ashby, B., & Liu-Chen, L. Y. (1993) · Biochemical Journal · doi:10.1042/bj2950629 · Cited by 197
MICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196
SEIDAH, N. G., DAY, R., MARCINKIEWICZ, M., & CHRÉTIEN, M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10727.x · Cited by 191
Fukuda, K., Kato, S., Morikawa, H., Shoda, T., & Mori, K. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031309.x · Cited by 190
Interactions between NPY and CRF in the amygdala to regulate emotionality
Sajdyk, T. J., Shekhar, A., & Gehlert, D. R. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.006 · Cited by 183
Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
Werling, L. L., Frattali, A., Portoghese, P. S., Takemori, A. E., & Cox, B. M. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21016-3 · Cited by 177
Jolas, T., & Aghajanian, G. K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00103-0 · Cited by 171
Zhu, J., Luo, L.-Y., Li, J., Chen, C., & Liu‐Chen, L. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36877-6 · Cited by 171
Wittmann, W., Schunk, E., Rosskothen, I., Gaburro, S., Singewald, N., Herzog, H., & Schwarzer, C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.142 · Cited by 165
Self-citationDynorphin A activates bradykinin receptors to maintain neuropathic pain
Lai, J., Luo, M.-C., Chen, Q., Ma, S., Gardell, L. R., Ossipov, M. H., & Porreca, F. (2006) · Nature Neuroscience · doi:10.1038/nn1804 · Cited by 160
Cell Death and Synaptic Reorganizations Produced by Seizures
Ben‐Ari, Y. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.042suppl.3005.x · Cited by 159
Gall, C. M. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-06-01852.1988 · Cited by 157
κ1 Receptor mRNA Distribution in the Rat CNS: Comparison to κ Receptor Binding and Prodynorphin mRNA
Mansour, A., Fox, C. A., Meng, F., Akil, H., & Watson, S. J. (1994) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1994.1015 · Cited by 154
Arvidsson, U., Riedl, M. S., Chakrabarti, S., Vulchanova, L., LEE, J., Nakano, A. H., Lin, X., Loh, H. H., Law, P., & Wessendorf, M. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5062 · Cited by 154
Salvinorin A: the ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor
Sheffler, D. J., & Roth, B. L. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00027-0 · Cited by 153
Prodynorphin Processing by Proprotein Convertase 2
Day, R. W., Lazure, C., Basak, A., Boudreault, A., Limperis, P., Dong, W., & Lindberg, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.829 · Cited by 148
Belcheva, M. M., Vogel, Z., Ignatova, E. G., Avidor‐Reiss, T., Zippel, R., Levy, R., Young, E. C., Barg, J., & Coscia, C. J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020635.x · Cited by 146
Surprenant, A., Shen, K., North, R. A., & Tatsumi, H. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018349 · Cited by 145
Is depression associated with dysfunction of the central reward system?
Martin-Söelch, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370313 · Cited by 144
Drake, C., Terman, G. W., Simmons, M., Milner, T. A., Kunkel, D. D., Schwartzkroin, P. A., & Chavkin, C. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-06-03736.1994 · Cited by 142
Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
Comer, S. D., Hoenicke, E. M., Sable, A., McNutt, R. W., Chang, K., de Costa, B. R., Mosberg, H. I., & Woods, J. H. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39544-3 · Cited by 142
Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary.
Fischli, W., D, A. G. M., Hunkapiller, M. W., & Hood, L. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.17.5435 · Cited by 141
Dynorphin-related immunoreactive peptides in rat brain and pituitary
Höllt, V., Haarmann, I., Bovermann, K., Jerlicz, M., & Herz, A. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90318-3 · Cited by 139
Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System
Tao, R., & Auerbach, S. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037861 · Cited by 138
Noradrenaline in mood and anxiety disorders: basic and clinical studies
Brunello, N., Blier, P., Judd, L. L., Mendlewicz, J., Nelson, C. J., Souery, D., Zohar, J., & Racagni, G. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200307000-00001 · Cited by 138
History and development of mixed opioid agonists, partial agonists and antagonists.
Martin, W. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb04700.x · Cited by 134
Loacker, S., Sayyah, M., Wittmann, W., Herzog, H., & Schwarzer, C. (2007) · Brain · doi:10.1093/brain/awl384 · Cited by 133
Self-citationThe effects of serotonin manipulations on emotional information processing and mood
Merens, W., van der Does, W. A. J., & Spinhoven, P. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.032 · Cited by 123
Weber, E., & Barchas, J. D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.4.1125 · Cited by 123
Isolation of a Human κ Opioid Receptor cDNA from Placenta
Mansson, E., Bare, L. A., & Yang, D. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2091 · Cited by 121
Differential effects of mu and kappa opioid systems on motivational processes.
Shippenberg, T. S., & Herz, A. (1986) · PsycEXTRA Dataset · doi:10.1037/e471872004-001 · Cited by 121
Kanamatsu, T., Obie, J. F., Grimes, L. M., McGinty, J. F., Yoshikawa, K., Sabol, S. L., & Hong, J. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-10-03094.1986 · Cited by 120
Faden, A. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00425.1992 · Cited by 118
Mathieu-Kia, A.-M., Fan, L.-Q., Kreek, M. J., Simon, E. J., & Hiller, J. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03302-3 · Cited by 118
Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus
Wagner, J. J., Caudle, R. M., & Chavkin, C. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-01-00132.1992 · Cited by 116
Morphological changes in the dentate gyrus in human temporal lobe epilepsy.
Houser, C. R. (1992) · PubMed · Cited by 115
Karlsson, R., Choe, J. S., Cameron, H. A., Thorsell, A., Crawley, J. N., Holmes, A., & Heilig, M. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0945-2 · Cited by 115
Decreased Oral Self-Administration of Alcohol In ??-Opioid Receptor Knock-Out Mice
Kovacs, K. M., Szakall, I., Brien, D. O., Wang, R., Vinod, K. Y., Saito, M., Simonin, F., Kieffer, B. L., & Vadász, C. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000164361.62346.d6 · Cited by 115
Rosen, J. B., Cain, C. J., Weiss, S. R. B., & Post, R. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90115-r · Cited by 114
Kreibich, A., Reyes, B. A. S., Curtis, A. L., Ecke, L. E., Chavkin, C., Bockstaele, E. J. V., & Valentino, R. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0390-08.2008 · Cited by 113
Iadarola, M. J., Shin, C., McNamara, J. O., et al. (1986) · Brain Research · doi:10.1016/0006-8993(86)90738-9 · Cited by 113
Jin, W., Lee, N. M., Loh, H. H., & Thayer, S. A. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09249-1 · Cited by 111
Linking emotion to the social brain: The role of the serotonin transporter in human social behaviour
Lesch, K. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401008 · Cited by 110
Cloning of a human κ opioid receptor from the brain
Zhu, J., Chen, C., Xue, J.-C., Kunapuli, S. P., DeRiel, J. K., & Liu‐Chen, L. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00507-o · Cited by 109
Rusin, K. I., Giovannucci, D. R., Stuenkel, E. L., & Moises, H. C. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-17-06565.1997 · Cited by 107
Stögmann, E., Zimprich, A. A., Baumgartner, C., Aull‐Watschinger, S., Höllt, V., & Zimprich, F. (2002) · Annals of Neurology · doi:10.1002/ana.10108 · Cited by 107
Opioid receptor selectivity of dynorphin gene products.
James, I. F., Fischli, W., & Goldstein, A. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21609-3 · Cited by 105
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
Barber, A., & Gottschlich, R. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.10.1351 · Cited by 105
Simmons, M. L., Terman, G. W., Gibbs, S. M., & Chavkin, C. (1995) · Neuron · doi:10.1016/0896-6273(95)90273-2 · Cited by 105
A new opioid octapeptide related to dynorphin from porcine hypothalamus
Minamino, N., Kangawa, K., Fukuda, A., Matsuo, H., & Iagarashi, M. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(80)80063-5 · Cited by 105
Broom, D. C., Jutkiewicz, E. M., Folk, J. E., Traynor, J. R., Rice, K. C., & Woods, J. H. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1179-y · Cited by 103
Involvement of the opioid system in the anxiolytic effect of diazepam in mice
Tsuda, M., Suzuki, T., Misawa, M., & Nagase, H. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00219-1 · Cited by 103
Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro
Moore, S., Madamba, S. G., Schweitzer, P., & Siggins, G. R. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-02-00809.1994 · Cited by 102
Non-opioid effects of dynorphins: possible role of the NMDA receptor
Shukla, V. K., & Lemaire, S. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90091-4 · Cited by 101
Minamino, N., Kangawa, K., Chino, N., Sakakibara, S., & Matsuo, H. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91243-2 · Cited by 101
A novel interaction between dynorphin(1–13) and an N-methyl-d-aspartate site
Caudle, R. M., & Isaac, L. (1988) · Brain Research · doi:10.1016/0006-8993(88)91628-9 · Cited by 100
Pierce, J. P., Kurucz, O. S., & Milner, T. A. (1999) · Hippocampus · doi:10.1002/(sici)1098-1063(1999)9:3<255::aid-hipo6>3.0.co;2-s · Cited by 100
Cavalleri, G. L., Lynch, J. M., Depondt, C., Burley, M., Wood, N. W., Sisodiya, S. M., & Goldstein, D. B. (2005) · Brain · doi:10.1093/brain/awh524 · Cited by 100
Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain
Hurd, Y. L. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00002-4 · Cited by 98
Control of hormonal stress reactivity by the endogenous opioid system
Bilkei‐Gorzó, A., Rácz, I., Michel, K., Mauer, D., Zimmer, A. M., Klingmüller, D., & Zimmer, A. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.010 · Cited by 97
Zhang, H., Shi, Y., Woods, J. H., Watson, S. J., & Ko, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.045 · Cited by 97
DePaoli, A. M., Hurley, K. M., Yasada, K., Reisine, T., & Bell, G. I. (1994) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1994.1039 · Cited by 95
You, Z. ‐., Herrera‐Marschitz, M., Nylander, I., Goiny, M., O'Connor, W. T., Ungerstedt, U., & Terenius, L. Y. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90540-1 · Cited by 95
MORRIS, B. J., Haarmann, I., Kempter, B., Höllt, V., & Herz, A. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90423-4 · Cited by 93
Kappa Opioid Receptor Inhibition of Glutamatergic Transmission in the Nucleus Accumbens Shell
Hjelmstad, G. O., & Fields, H. L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.3.1153 · Cited by 90
Quantitative autoradiography of μ-,δ- and κ1 opioid receptors in κ-opioid receptor knockout mice
Slowe, S. J., Simonin, F., Kieffer, B. L., & Kitchen, I. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01201-3 · Cited by 90
Pro-dynorphin peptides are found in the same neurons throughout rat brain: immunocytochemical study.
Watson, S. J., Khachaturian, H., Taylor, L. P., Fischli, W., D, A. G. M., & Akil, H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.3.891 · Cited by 90
Broom, D. C., Nitsche, J. F., Pintar, J. E., Rice, K. C., Woods, J. H., & Traynor, J. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.036525 · Cited by 89
Desipramine Reduces Stress-Activated Dynorphin Expression and CREB Phosphorylation in NAc Tissue
Chartoff, E. H., Papadopoulou, M., MacDonald, M. L., Parsegian, A., Potter, D. N., Konradi, C. L., & Carlezon, W. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051417 · Cited by 89
Reduced alcohol consumption in mice lacking preprodynorphin
Blednov, Y. A., Walker, D., Martinez, M., & Harris, R. A. (2006) · Alcohol · doi:10.1016/j.alcohol.2006.12.002 · Cited by 88
Wan, W., Ennulat, D. J., & Cohen, B. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00544-z · Cited by 88
Translocation of Dynorphin Neuropeptides across the Plasma Membrane
Marinova, Z., Vukojević, V. B., Surcheva, S. K., Yakovleva, T., Cebers, G., Pasikova, N. V., Усынин, И. Ф., Hugonin, L., Fang, W., Hallberg, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412494200 · Cited by 88
Defective Prodynorphin Processing in Mice Lacking Prohormone Convertase PC2
Berman, Y. L., Mzhavia, N., Polonskaia, A., Furuta, M., Steiner, D. F., Pintar, J. E., & Devi, L. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751763.x · Cited by 87
Immunoreactive dynorphin in human brain and pituitary
Gramsch, C., Höllt, V., Pasi, A., Mehraein, P., & Herz, A. (1982) · Brain Research · doi:10.1016/0006-8993(82)90930-1 · Cited by 85
Generation of dynorphin knockout mice
Sharifi, N., Diehl, N. L., Yaswen, L. R., Brennan, M. B., & Hochgeschwender, U. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00264-3 · Cited by 84
U50,488, a highly selective kappa opioid: anticonvulsant profile in rats.
Tortella, F. C., Robles, L. E., & Holaday, J. W. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24991-6 · Cited by 84
Neuropathic pain: the paradox of dynorphin.
Lai, J., Ossipov, M. H., Vanderah, T. W., et al. (2001) · PubMed · Cited by 83
A Longitudinal Study of Life Stress and Social Support among Drug Abusers
Rhoads, D. L. (1983) · International Journal of the Addictions · doi:10.3109/10826088309027352 · Cited by 82
Simonato, M., & Romualdi, P. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00045-7 · Cited by 82
Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis
Bakshi, R., & Faden, A. I. (1990) · Brain Research · doi:10.1016/0006-8993(90)90512-a · Cited by 81
Dynorphin A as a Potential Endogenous Ligand for Four Members of the Opioid Receptor Gene Family
Zhang, S., Tong, Y., Tian, M., DeHaven, R. N., Cortes-Burgos, L. A., Mansson, E., Simonin, F., Kieffer, B. L., & Yu, L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37567-6 · Cited by 80
McFadzean, I., Lacey, M. G., Hill, R. G., & Henderson, G. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90015-7 · Cited by 79
Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats
Marı́n, S., Marco, E. M., Biscaia, M., Fernández, B., Rubio, M., Guaza, C., Schmidhammer, H., & Viveros, M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01041-9 · Cited by 78
Mechanisms of Induction of Persistent Nociception by Dynorphin
Laughlin, T. M., Larson, A. A., & Wilcox, G. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29295-8 · Cited by 78
CRH Overproduction in Transgenic Mice: Behavioral and Immune System Modulationa
Stenzel‐Poore, M. P., Duncan, J. E., Rittenberg, M. B., Bakke, A. C., & Heinrichs, S. C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb15110.x · Cited by 77
Hurd, Y. L., Herman, M. M., Hyde, T. M., Bigelow, L. B., Weinberger, D. R., & Kleinman, J. E. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000319 · Cited by 75 · cited 2×
“, 1991) and in the caudate, putamen and accumbens nuclei (Hurd et al., 1997) of schizophrenia patients.”
BackgroundDynorphin and stress‐related peptides in rat locus coeruleus: Contribution of amygdalar efferents
Reyes, B. A. S., Drolet, G., & Bockstaele, E. J. V. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21683 · Cited by 75
Kuzmin, A., Madjid, N., Terenius, L. Y., Ögren, S. O., & Bakalkin, G. Y. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300959 · Cited by 74
Ploj, K., Roman, E., Gustavsson, L., & Nylander, I. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00328-2 · Cited by 73
Pascoe, J. E., Williams, K. L., Mukhopadhyay, P., Rice, K. C., Woods, J. H., & Ko, M. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.01.006 · Cited by 73
Merchenthaler, I., Maderdrut, J. L., Cianchetta, P., Shughrue, P. J., & Bronstein, D. M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970728)384:2<211::aid-cne4>3.0.co;2-4 · Cited by 71
Prodynorphin storage and processing in axon terminals and dendrites
Yakovleva, T., Bazov, I., Cebers, G., Marinova, Z., Hara, Y., Ahmed, A. S., Vlaskovska, M. V., Johansson, B. A., Hochgeschwender, U., Singh, I. N., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6174fje · Cited by 71
DOUGLASS, J. O., McKinzie, A. A., & Pollock, K. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.3.8015551 · Cited by 70
Opioid receptors: past, present and future
Mansour, A., Watson, S. J., & Akil, H. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80024-v · Cited by 67
Clarke, S., Zimmer, A., Zimmer, A., Hill, R. G., & Kitchen, I. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.07.011 · Cited by 65
Relationship between hippocampal opioid peptides and seizures
Hong, J., McGinty, J. F., Lee, P. H. K., Xie, C. W., & Mitchell, C. L. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90020-s · Cited by 64
Dynorphins: Similar relative potencies on μ-, δ- and κ-opiate receptors
Quirion, R., & Pert, C. B. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90125-4 · Cited by 62
Kudryavtseva, N. N., Gerrits, M. A. F. M., Avgustinovich, D. F., Tenditnik, M. V., & van Ree, J. M. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.005 · Cited by 59
Peckys, D. B., & Hurd, Y. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00525-1 · Cited by 58
Mutant models for genes associated with schizophrenia
Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370308 · Cited by 58
Dynorphin and the kappa 1 ligand [3H]U69,593 binding in the human epileptogenic hippocampus
de Lanerolle, N. C., Williamson, A., Meredith, C., Kim, J. H., Tabuteau, H., Spencer, D. D., & Brines, M. L. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00044-2 · Cited by 57
Opioid Modulation of Recurrent Excitation in the Hippocampal Dentate Gyrus
Terman, G. W., Drake, C. T., Simmons, M. L., Milner, T. A., & Chavkin, C. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04379.2000 · Cited by 56
Opioid precursor gene expression in the human hypothalamus
Sukhov, R. R., Walker, L. C., Rance, N., Price, D. L., & Young, W. (1995) · The Journal of comparative neurology · doi:10.1002/cne.903530410 · Cited by 56
Jeub, M., Lie, A. A., Blümcke, I., Elger, C. E., & Beck, H. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00249-3 · Cited by 56
Madamba, S. G., Schweitzer, P., & Siggins, G. R. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.4.1768 · Cited by 56
Cited by
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“Another opioid receptor gaining attention in the field of fear extinction is the KOR, activated by endogenous dynorphins (reviewed in Schwarzer, 2009).”
BackgroundThe role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398
Current Research on Opioid Receptor Function
Feng, Y., He, X., Yang, Y., Chao, D., H. Lazarus, L., & Xia, Y. (2012) · Current Drug Targets · doi:10.2174/138945012799201612 · Cited by 329
Role of kappa-opioid receptors in stress and anxiety-related behavior
Van’t Veer, A., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 257
Metadata
- Authors
- Schwarzer, C.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 123
- Issue
- 3
- Pages
- 353-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1975064257
- Cited by
- 289
- References
- 270
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.